The Risk of AKI in Patients Treated with Intravenous Solutions Containing Hydroxyethyl Starch
Authors:
Open Access
- 1 March 2013
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 8 (3) , 497-503
Abstract
Summary: Intravenous fluids are arguably one of the most commonly administered inpatient therapies and for the most part have been viewed as part of the nephrologist’s toolkit in the management of acute kidney disease. Recently, findings have suggested that intravenous fluids may be harmful if given in excess (quantitative toxicity) and that some may be more harmful than others (qualitative toxicity), particularly for patients who already have AKI. Recent clinical trials have investigated hydroxyethyl starch solutions and found worrying results for the renal community. In this brief review, we consider the published literature on the role of hydroxyethyl starch solutions in AKI, with particular emphasis on two large recent randomized clinical trials conducted in Europe and Australia.Keywords
This publication has 41 references indexed in Scilit:
- Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive CareNew England Journal of Medicine, 2012
- Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe SepsisNew England Journal of Medicine, 2012
- Intraoperative fluids: how much is too much?British Journal of Anaesthesia, 2012
- Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS studyCritical Care, 2012
- Microcirculatory alterations: potential mechanisms and implications for therapyAnnals of Intensive Care, 2011
- Fluids after cardiac surgery: A pilot study of the use of colloids versus crystalloids*Critical Care Medicine, 2010
- Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survivalKidney International, 2010
- Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia*Critical Care Medicine, 2009
- Crystalloids versus colloids for goal-directed fluid therapy in major surgeryCritical Care, 2009
- Hydroxyethylstarch impairs renal function and induces interstitial proliferation, macrophage infiltration and tubular damage in an isolated renal perfusion modelCritical Care, 2009